Banz, Kurt; Dinkel, Rolf; Hanefeld, Markolf; … - In: PharmacoEconomics 13 (1998) 4, pp. 449-459
type 2 diabetes mellitus is usually initiated with glibenclamide (glyburide), which is known to increase bodyweight … (reflecting group B). The novel alpha-glucosidase inhibitor acarbose, in contrast, appears to be as effective as glibenclamide … considered an alternative to glibenclamide. From the viewpoint of drug costs, monotherapy with acarbose is 4 times as expensive …